|
No Reprieve for Pharma as Third Circuit Refuses to Stay K-Dur Anti Pay-for-Delay Ruling
Drugmakers operating in the Third Circuit Court of Appeals jurisdiction will need to remain cautious about engaging in reverse patent settlements as the court refused to put on hold its recent ruling that such deals are anticompetitive while Merck and Upsher-Smith appeal to the Supreme Court.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives